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Objectives: Patients with dilated cardiomyopathy (DCM) may have a high incidence of 
clinically asymptomatic silent cerebral infarction (SCI). Prevalence of SCI and its risk factors 
may differ between ischemic and nonischemic DCM. The purpose of this study was to evaluate 
prevalence and related parameters of silent cerebral infarction in patients with ischemic and 
nonischemic DCM.
Methods: Patients with ischemic and nonischemic DCM (53 male, 19 female, aged 62 ± 12 
years) were included in the study. Etiology of DCM was ischemic in 46 and nonischemic in 26 
patients. Fifty-six age- and gender-matched healthy volunteers served as a control group for 
comparison of SCI prevalence.
Results: Prevalence of SCI was 39%, 27%, and 3.6% in ischemic, nonischemic DCM, and 
control group, respectively (ischemic DCM vs control group, p   0.001, nonischemic DCM 
vs control group, p = 002). In patients with nonischemic DCM, the mean age of the subjects 
with SCI was signiﬁ  cantly higher than that of subjects without lesions (67 ± 5 years vs 53 ± 13, 
p   0.001), whereas in ischemic DCM NHYA Functional Class was statistically higher in 
patients with SCI than without SCI (p = 0.03). In both groups, patients with SCI had lower 
systolic functions than patients with normal MRI ﬁ  ndings. In multivariable logistic regression 
analysis, restrictive type of diastolic ﬁ  lling pattern was found as an independent factor for SCI 
occurrence on the whole patient population (OR: 16.5, 95% CI: 4.4–61.8, p   0.001).
Conclusion: SCI is common in patients with both ischemic and nonischemic DCM. In univariate 
analysis, both groups have similar systolic and diastolic characteristics in the occurrence of SCI. 
Logistic regression analysis revealed that restrictive diastolic ﬁ  lling pattern is an independent 
risk factor in the occurrence of SCI for the whole patient population.
Keywords: ischemic dilated cardiomyopathy, nonischemic dilated cardiomyopathy, silent 
cerebral infarction, restrictive diastolic ﬁ  lling, age, functional status
A silent cerebral infarction (SCI) is classiﬁ  ed as a type III cerebrovascular disorder 
by the National Institute of Neurological Disorders and Stroke (NINDS 1990). In 
the general population, prevalence of SCI varies between 10% and 28%, whereas in 
patients with stroke it is as high as 38% (Kase et al 1989; Ricci et al 1993; Price et al 
1997; Howard et al 1998; Vermeer et al 2002). SCI was identiﬁ  ed as a risk factor for 
clinical stroke (Kobayashi et al 1997). It may be related to dementia, cognitive deﬁ  cits, 
and depression (Yamashita et al 2001; Maeshima et al 2002; Liebetrau et al 2004). 
To prevent SCI, it is important to know its related factors, especially preventable or 
treatable risk factors.
Ischemic and nonischemic dilated cardiomyopathies are important reasons for 
chronic heart failure (Douglas et al 2004). Dilated cardiomyopathy (DCM) is associ-
ated with an increased risk of thromboembolism because of low output state, relative 
stasis of blood in a dilated chamber, and altered coagulation status (Koniaris and 
Goldhaber 1998). The reported incidence of thromboembolism in the chronic heart Vascular Health and Risk Management 2008:4(2) 464
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failure population varies widely, ranging from 2.7% to 22% 
(Cleland 1997). The prevalence of silent ischemic stroke was 
34% in patients with heart failure (Siachos et al 2005). The 
prevalence of SCI, related risk factors, and characteristics 
may differ between patients with ischemic and nonischemic 
cardiomyopathies. The purpose of this study was to evaluate 
the prevalence and related parameters of SCI in patients with 
ischemic and nonischemic dilated cardiomyopathies.
Methods
Patient selection
Ninety patients with DCM, with New York Heart Asso-
ciation (NYHA) II-IV Functional Classiﬁ  cation, diagnosed 
according to WHO criteria (WHO 1996) were recruited for 
the study. Patients with poor acoustic window, heart valve 
disease with hemodynamic signiﬁ  cance, atrial ﬁ  brillation, 
uncontrolled ventricular arrythmias, atrio ventricular block, 
previous transient ischemic attack or stroke, or neurological 
deﬁ  cit secondary to cerebral pathology were excluded from 
the study (n = 18). The remaining 72 patients (53 males, 
19 females; mean age 62 ± 12 years) comprised the study 
group. Etiology of the DCM was investigated by coronary 
angiography in all patients. All patients underwent coronary 
angiography to determine coronary artery disease before 
magnetic resonance imaging (MRI) studies.
Forty-six of the patients had ischemic dilated cardiomy-
opathies and 26 had nonischemic dilated cardiomyopathies. 
In all patients, left ventricular enlargement (end-diastolic 
diameter  56 mm) and systolic dysfunction (ejection frac-
tion  45%) were documented by 2-dimensional and M-mode 
echocardiography.
Fifty-six, age- and gender-matched healthy volunteers (36 
males, 20 females; mean age 61 ± 10 years) were accepted 
as a control group after routine clinical and laboratory 
evaluation.
The study was conducted in accordance with the Declara-
tion of Helsinki. Study protocol was approved by the local 
ethics committee and subjects gave informed consent prior 
to study entry.
Echocardiography
Transthoracic 2-dimensional and Doppler echocardio-
graphic assessments were performed by a Toshiba SSA-390 
A ultrasound machine using a 2.5 MHz transducer. Mea-
surements of the left atrium, and left and right ventricles 
were obtained from parasternal long axis view as recom-
mended by the American Society of Echocardiography 
(Sahn et al 1978). Left ventricular ejection fraction was 
calculated using the modiﬁ  ed Simpson’s rule in the apical 
2- and 4-chamber views. Spontaneous echo contrast in 
the left ventricle (LVSEC) was categorized as ‘present’ 
or ‘absent’ by harmonic imaging. Mitral ﬂ  ow pattern was 
evaluated from the apical 4-chamber view with pulsed-
wave Doppler by placing a sample volume at the tips of 
mitral leaﬂ  ets during diastole. Early (E) and atrial (A) peak 
velocities, the E/A ratio, deceleration time of early ﬁ  lling, 
isovolumic relaxation time, and pulmonary vein ﬂ  ow pat-
tern were measured on three separate beats and averaged. 
Four types of diastolic ﬁ  lling pattern were considered: 
normal filling, relaxation abnormality, pseudonormal 
pattern, and restrictive ﬁ  lling. Left atrial maximum and 
minimum volumes (LAVmax and LAVmin) were determined 
from orthogonal apical views using biplane area-length 
method. Left atrial total emptying fraction was estimated 
as follows: 100x (LAVmax−LAVmin)/LAVmax.
There were good agreements between the two indepen-
dent observers’ measurements of ejection fraction (r = 0.90, 
mean difference ± 4%) and grade of spontaneous echo con-
trast (r = 0.91), and between the two measurements made by 
the investigator (ejection fraction: r = 0.98, mean difference 
± 2%; spontaneous echo contrast: r = 0.99).
Blood samples
Fasting blood samples were drawn from a large antecubital 
vein of each patient for detecting biochemical and hemostatic 
parameters before transthoracic echocardiography examina-
tion. White blood cells and platelets counts, and hematocrit, 
lipid, creatin, C-reactive protein levels, and sedimentation 
rate were measured by standard methods. The plasma ﬁ  brino-
gen was measured by the STA Compact auto analyser using 
the STA® – Fibrinogen kit.
Neurological examination and brain 
magnetic resonance imaging
Neurological examination of the study and control groups 
was performed by a qualiﬁ  ed neurologist. Patients and con-
trol group were examined with MRI to detect SCI. Cerebral 
MRI was performed on a 1.5-T MR scanner (Philips Intera 
Master, Eindhoven, Netherlands) using a standard quadrature 
head coil. After obtaining scout images, routine imaging was 
performed. Our routine magnetic resonance imaging (MRI) 
protocol for cerebral disease includes axial dual echo TSE, 
axial FLAIR, axial T1-weighted TSE, sagittal T2-weighted 
TSE, and coronal T2-weighted TSE images. All images were 
acquired with a ﬁ  eld of view of 230 × 230 mm, and a section 
thickness of 5 mm with a 1-mm intersection gap.Vascular Health and Risk Management 2008:4(2) 465
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A neuroradiologist, kept unaware of the clinical status of 
the patients, reviewed hard copies of the images. SCI was 
deﬁ  ned as a focal hyper-intense lesion  5 mm in diameter 
both on T2-weighted and FLAIR images, which was also 
hypo-intense on T1-weighted images. Periventricular hyper-
intense lesions, subcortical patchy, or conﬂ  uent hyper-intense 
lesions were not included (Maeshima et al 2002).
Statistical analysis
Statistical analysis was performed with SPSS 13.0 software. 
Results are expressed as mean ± standard deviation. The fre-
quency of SCI in patients and control groups was compared 
with results from a chi-square test. Continuous variables of 
the patients with and without SCI were compared by unpaired 
Student t-test. If necessary, the Mann Whitney U test was 
used instead of Student t-test and categorical variables were 
compared with the chi-square test. Interaction between 
parameters that could be relevant for the formation of SCI 
was calculated by multivariate forward stepwise logistic 
regression analysis, adjusting for age, ejection fraction, 
restrictive diastolic ﬁ  lling, and coronary artery disease. A p 
value  0.05 was considered signiﬁ  cant.
Results
Demographic, clinical, and echocardiographic character-
istics of patients with ischemic and nonischemic DCM are 
shown in Table 1. Prevalence of SCI was 39%, 27%, and 
3.6% in ischemic, nonischemic DCM, and the control group, 
respectively (ischemic DCM vs control group, p   0.001; 
nonischemic DCM vs control group, p = 002).
Ischemic DCM patients with and without 
SCI
As demonstrated in Table 2, the NYHA Functional Classiﬁ  -
cation was statistically different in patients with and without 
SCI (p = 0.03). Among ischemic DCM patients, the number 
of males with SCI was higher than those without SCI, but the 
difference was not statistically signiﬁ  cant (p = 0.059). Other 
variables including age, body mass index, medical treatment, 
the prevalence of coronary artery disease, hypertension, 
diabetes, and dyslipidemia were not statistically different in 
both groups (some data are not shown).
Patients with SCI had lower hematocrit levels and higher 
creatinine levels than those without SCI (p = 0.054, p = 0.017, 
respectively). Although ﬁ  brinogen level was higher in the 
SCI group than the other group, the difference was not 
statistically signiﬁ  cant (4.58 ± 0.61 vs 4.36 ± 0.98 g/L) 
(Table 2).
The echocardiographic findings are summarized in 
Table 3. End-diastolic and end-systolic left ventricular 
dimensions, left atrium size, and LV-SEC was similar 
between two groups. However, the ejection fraction and 
cardiac index were lower in patients with SCI than without 
SCI (p = 0.03, p = 0.01, respectively). The percentage of 
restrictive diastolic ﬁ  lling pattern was higher in patients with 
SCI than without SCI in ischemic DCM (p   0.001).
Nonischemic DCM patients with SCI and 
without SCI
The mean age was higher in patients with SCI than without 
SCI (67 ± 5 vs 53 ± 13 years, p   0.001). No signiﬁ  cant 
difference was observed between two groups with respect 
to gender, NYHA Functional Classiﬁ  cation, or body mass 
index. The other variables including medical treatment, the 
prevalence of coronary artery disease, hypertension, diabe-
tes, and dyslipidemia were not statistically different in both 
groups (data are not shown).
The echocardiographic parameters that were observed in 
two groups are shown in Table 4. Left ventricular systolic 
Table 1 Demographic, clinical, and echocardiographic character-
istics of patients with ischemic and nonischemic DCM
 Ischemic  Nonischemic  P
 DCM  DCM
 (n  = 46)  (n = 26) 
Prevalence of SCI  18 (39%)  7 (%27)  NS
Gender (male/female)  37/9  16/10  NS
Age (years)  64 ± 10  57 ± 13  0.012
NHYA functional   3.0 ± 0.8  3.0 ± 0.8  NS
classiﬁ  cation
Previous hypertension  29 (%63)  11 (%42)  NS
Diabetes mellitus  19 (%41)  3 (%1)  0.008
Dyslipidemia   9 (%20)  9 (%35)  NS
Body mass index (kg/m²)  26 ± 4  26 ± 3  NS
Drug use (%)      NS
Digitalis   19 (%41)  11 (%42)  NS
ACEI/ARB   31 (%67)  17 (%65)  NS
Diuretics  26 (%57)  16 (%62)  NS
Spiranolactone   5 (%10)  2 (%1)  NS
Beta-blockers   5 (%10)  7 (%27)  NS
Aspirin  39 (%85)  17 (%65)  0.057
LVDD (mm)  65 ± 7  69 ± 10  0.055
LVSD (mm)  54 ± 7  57 ± 10  NS
Ejection fraction (%)  32 ± 9  31 ± 10  NS
Left atrial diameter (mm)  45 ± 5  44 ± 6  NS
Right ventricular diameter (mm)  28 ± 4  28 ± 7  NS
Abbreviations: SCI, silent cerebral infarction; NYHA, New York Heart 
Association;   ACE-I/ARB,   ACE-inhibitors/angiotensin II receptor antagonists; LVDD, 
Left ventricular end-diastolic diameter; LVSD, Left ventricular end-systolic diameter; 
NS, Nonsigniﬁ  cant.Vascular Health and Risk Management 2008:4(2) 466
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function-related parameters such as ejection fraction and 
systolic shortening were lower in patients with SCI, whereas 
cardiac chambers dimensions, as well as presence of LV-SEC, 
were not different between the groups. Percentage of restric-
tive diastolic ﬁ  lling pattern was higher in patients with SCI 
than without SCI in nonischemic DCM (p = 0.017). Although 
nonischemic DCM patients with SCI had higher ﬁ  brinogen 
levels than the other group, the difference was not statistically 
signiﬁ  cant (4.60 ± 1.10 vs 4.24 ± 1.26 g/L).
Multiple logistic regression analysis
In multivariable logistic regression analysis, restrictive type 
of diastolic ﬁ  lling pattern was found as an independent factor 
for SCI occurrence for the whole patient population (OR: 
16.5, 95% CI: 4.4–61.8, p   0.001).
Discussion
SCI was observed in 39% of patients with ischemic DCM. 
Higher NHYA Functional Classiﬁ  cation, lower ejection 
fraction and cardiac index, decreased hematocrit level, and 
increased creatinine level were determinants for SCI in this 
patient group.
A heart failure group was investigated by Siachos and 
colleagues (2005) for SCI. The prevalence of silent stroke 
was 34% in this patient group. The group comprised nonisch-
emic and ischemic cardiomyopathy patients. Traditional 
risk factors such as age, gender, history of hypertension, 
and diabetes mellitus were not predictive for silent stroke 
in heart failure patients. Their ﬁ  ndings were similar to our 
data. Among all our patients, the prevalence of SCI was 35% 
(Kozdag et al 2006).
In the general population, prevalence of SCI varies 
between 10% and 28%, whereas in patients with stroke it 
is as high as 38% (Kase et al 1989; Ricci et al 1993; Price 
et al 1997; Howard et al 1998; Vermeer et al 2002). Our 
patient group had higher prevalence of SCI than the general 
population but had a similar prevalence for SCI as patients 
with stroke. This ﬁ  nding is very interesting for this patient 
group. It is known that coronary artery disease and cerebro-
vascular disease frequently coexist and have similar risk 
factors. A patient with ischemic stroke usually has coronary 
artery disease and its manifestations (Sandercock et al 1989). 
Patients with a history of coronary artery disease events show 
a tendency to have higher cerebrovascular events than those 
without a history of coronary artery disease events (Reicher-
Reiss et al 1998). Advanced SCI also may relate to common 
coronary artery disease (Hoshide et al 2001). Our ﬁ  ndings 
agree with the above-mentioned data for cerebrovascular 
disease in patients with ischemic cardiomyopathy who have 
coronary artery disease and high prevalence of SCI. It may 
be speculated for this patient group that unknown hemody-
namic variations, low output states, silent atrial arrhythmias, 
cardiac catheterization, and advanced atherosclerosis may 
either decrease cranial blood ﬂ  ow or increase embolic events 
in patients with ischemic DCM.
The present study showed that higher NHYA Functional 
Classiﬁ  cation was related to SCI only in ischemic DCM. As 
expected, patients with poor functional status who have SCI 
also have decreased cardiac index, lower ejection fraction, 
impaired renal function, and low hematocrit level. Decreased 
ejection fraction in females was shown as a risk factor for overt 
strokes in large heart failure trials (Dries et al 1997). The Sur-
vival and Ventricular Enlargement (SAVE) trial (Pfeffer et al 
1992) reported the incidence of stroke as 1.5/100 patient-years 
in patients who had left ventricular dysfunction after acute 
myocardial infarction. Patients with ejection fractions of  28% 
after myocardial infarction had a relative risk of stroke of 1.86 
compared with patients with ejection fractions  35%, and an 
18% increase in the risk of stroke was documented for every 
5% decrease in ejection fraction (Loh et al 1997). Decreased 
ejection fraction seems an important determinant for overt 
stroke and SCI in patients with coronary artery disease.
Büsing and colleagues (2005) prospectively evaluated 
patients who had undergone cardiac catheterization with 
MRI studies before and after the procedure. It was found 
that 15% patients had new SCIs after the procedure. There 
was no relevant difference with regard to pre-existing 
Table 2 Demographic, clinical, hematological, and biochemical 
parameters of ischemic DCM patients with and without SCI
 SCI  (+) SCI  (−) P
 (n  = 18)  (n = 28)
Gender (male/female)  6/12  3/25  0.059
Age (years)  65 ± 12  64 ± 8  NS
NHYA functional  3.3 ± 0.8  2.8 ± 0.8  0.03
classiﬁ  cation
Body mass index (kg/m²)  26 ± 5  25 ± 3  NS
Hematocrit (volume fraction)  0.37 ± 0.04  0.40 ± 0.05  0.054
Sedimentation rate (mm/hour)  21 ± 16  23 ± 25  NS
Fasting glucose level (mmol/L)  6.9 ± 2.8  6.6 ± 2.3  NS
Cholesterol (mmol/L)  4.3 ± 1.0  4.2 ± 0.8  NS
HDL-C (mmol/L)  0.9 ± 0.2  0.9 ± 0.3  NS
LDL-C (mmol/L)  2.8 ± 0.8  3.0 ± 0.8  NS
Tryglyceride (mmol/L)  1.2 ± 0.5  1.0 ± 0.4  NS
Creatinine (µmol/L)  122 ± 35  96 ± 27  0.017
Fibrinogen (g/L)  4.58 ± 0.61  4.36 ± 0.98  NS
CRP (mg/L)  9.8 ± 15  13 ± 23  NS
Abbreviations: SCI (+), patients with silent cerebral infarction; SCI (−), patients 
without silent cerebral infarction; CRP, C-reactive protein; NS, not signiﬁ  cant.Vascular Health and Risk Management 2008:4(2) 467
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cardiovascular abnormalities such as impaired ejection 
fraction and arrythmias. Only duration of cardiac catheter-
ization was found as an independent predictor of occurrence 
of cerebral infarction (Büsing et al 2005). The rate of SCI 
after cardiac catheterization seems to be higher than it is for 
clinically symptomatic stroke which was reported as 0.11% 
(Segal et al 2001). Similarly, patients with coronary bypass 
grafting had increased incidence of SCI (Friday et al 2005). 
Besides low output states and advanced atherosclerosis, those 
procedures mentioned above may contribute to occurrence of 
SCI. It may be speculated that a patient with ischemic DCM 
who has high NHYA Functional Classiﬁ  cation, relatively 
decreased systolic function, impaired renal function, and 
lower hematocrit level has a higher risk of developing SCI 
than a patient without those characteristics. We may include 
the cardiac catheterization procedure and coronary bypass 
grafting are risks factors in this patient group.
SCI was determined in 27% of patients with nonischemic 
DCM. Older age and impaired systolic function were found as 
the determinants for SCI in this group. According to previous 
studies, the occurrence of SCI increases with age (Longstreth 
et al 2002; Vermeer et al 2002). In the Atherosclerosis Risk in 
Communities (ARIC) study, the prevalence of SCI was 7.9% 
in patients between 55 and 59 years of age and 22.9% in those 
between 65 and 72 years of age (Bryan et al 1999). Kotani and 
colleagues (2004) studied an elderly population whose mean 
age was 77.5 ± 8.7 years. They observed SCI in 48% of their 
elderly population (Kotani et al 2004). Schmidt and colleagues 
(1991) observed cerebral infarcts in 20% of 20 neurologically 
asymptomatic patients with idiopathic DCM. Their patients 
were younger than our patients and Kotani’s patients. In the 
present study, older patients with nonischemic DCM had more 
SCI lesions than younger patients. The prevalence of SCI 
increased with age in the previous studies in agreement with our 
ﬁ  nding. It seems that increased age is important for occurrence 
of SCI. As expected, the older patients had greater risk than 
younger patients for occurrence of SCI in the present study.
Patients with nonischemic DCM had similar charac-
teristics as those with ischemic DCM, such as an enlarged 
cardiac chamber, systolic impairment, stagnant blood, and 
silent atrial arrhythmias for SCI. Impaired systolic function 
parameters such as decreased left ventricular ejection fraction 
and systolic shortening were observed in this patient group. 
All these parameters may cause silent embolic events to brain 
in this patient group, as does ischemic cardiomyopathy.
Multivariable analysis showed that restrictive ﬁ  lling 
pattern was an independent risk factor for occurrence of 
SCI. Restrictive ﬁ  lling pattern in mitral ﬂ  ow is a marker for 
markedly impaired left ventricular ﬁ  lling and may show atrial 
systolic failure (Vanoverschelde et al 1990). Either left atrial 
systolic failure or stagnant milieu in the left atrium may cause 
embolic events. Enlarged and dysfunctional left atrium may 
cause silent arrythymias such as atrial ﬁ  brillation in patients 
with ischemic and nonischemic DCM.
Implications
The present study showed that both groups have similar 
characteristics for the occurrence of SCI such as impaired 
systolic function and restrictive ﬁ  lling pattern. Ischemic DCM 
patients with SCI had advanced disease stage characteristics 
such as increased creatinine level and decreased hematocrite 
level compared with patients without SCI. Nonischemic DCM 
Table 3 Echocardiographic parameters of ischemic DCM 
patients with and without SCI
  SCI (+)  SCI (−) P
 (n  = 18)  (n = 28)
LVDD (mm)  65 ± 7  64 ± 6  NS
LVSD (mm)  55 ± 7  53 ± 7  NS
Ejection fraction (%)  29 ± 7  34 ± 9  0.03
Fractional shortening (%)  15 ± 4  17 ± 5  NS
LA (mm)  46 ± 6  45 ± 4  NS
Left atrial total emptying  39 ± 16  42 ± 12  NS
fraction (%)
CI (L/min/m²)  2.4 ± 0.7  2.0 ± 0.4  0.01
LVSEC (n, %)  8 (44%)  8 (29%)  NS
Restrictive ﬁ  lling pattern (n, %)  12 (67%)  3 (11%)   0.001
Abbreviations: SCI (+), patients with silent cerebral infarction; SCI (−), patients 
without silent cerebral infarction; LVDD, left ventricular end-diastolic diameter; LVSD, 
left ventricular systolic diameter; LA, left atrium diameter; EF, ejection fraction; CI, 
cardiac index; LVSEC, left ventricular spontaneous echo contrast; NS, not signiﬁ  cant.
Table 4 Echocardiographic parameters of nonischemic DCM 
patients with and without SCI
 SCI  (+)   SCI (−)   P
 (n  = 7) (n  = 19)
LVDD (mm)  70 ± 11  69 ± 10  NS
LVSD (mm)  59 ± 12  57 ± 10  NS
Ejection fraction (%)  24 ± 8  33 ± 10  0.05
Fractional shortening (%)  12 ± 4  17 ± 5  0.02
LA (mm)  43 ± 7  44 ± 6  NS
Left atrial total emptying   38 ± 4  40 ± 12  NS
fraction (%)
CI (L/min/m²)  2.2 ± 0.9  2.5 ± 0.8  NS
LVSEC (n, %)  4 (57%)  7 (37%)  NS
Restrictive ﬁ  lling pattern (n, %)  5 (71%)  4 (21%)  0.017
Abbreviations: SCI (+), patients with silent cerebral infarction; SCI (−), patients 
without silent cerebral infarction; LVDD, left ventricular end-diastolic diameter; LVSD, 
left ventricular systolic diameter; LA, left atrium diameter; EF, ejection fraction; CI, 
cardiac index; LVSEC, left ventricular spontaneous echo contrast; NS, not signiﬁ  cant.Vascular Health and Risk Management 2008:4(2) 468
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patients with SCI were older than those without SCI. It was 
shown that left ventricular diastolic ﬁ  lling characteristics 
were correlated with NYHA Functional Class (NINDS 1990). 
Ischemic DCM patients with SCI had higher NYHA Functional 
Class than patients without SCI and restrictive ﬁ  lling pattern 
in the present study. Advanced disease stage characteristics 
may be important for the occurrence of SCI. It may be 
important to prevent or immediately treat decompensation of 
heart failure, renal failure, and anemia in this patient group. 
Freudenberger suggested that left ventricular dysfunction 
needs more aggressive treatment and the physician has to 
be alert for silent atrial ﬁ  brillation episodes for a patient 
with chronic heart failure (Freudenberger and Massie 2005). 
Patients who have dilated cardiomyopathy usually undergo 
cardiac catheterization for the etiology of the disease. This 
procedure may increase the occurrence of SCI in patients 
with DCM when compared to patients who do not have the 
procedure. This patient population requires extra careful 
attention their treatment to prevent occurrence of overt stroke. 
Patients with advanced-stage disease characteristics may take 
anticoagulation therapy to prevent overt stroke in ischemic 
DCM. Older patients who have decreased ejection fraction, 
fractional shortening, and restrictive ﬁ  lling pattern may be 
given anticoagulation therapy to protect them from stroke in 
nonischemic DCM. It was determined that 3-year mortality 
rate was increased by symptomatic and silent infarcts in 
elderly people (Liebetrau et al 2004). Patients with SCI may 
have a higher mortality rate than those without SCI in DCM. 
Follow-up studies are necessary to determine the relation 
between mortality and SCI in patients with DCM.
Study limitations
Because MRI is an expensive tool for investigation, a small 
patient numbers were included in the present study. Our 
data will support other research which should include more 
patients than did our research.
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